BioSpace News Archive

Engineered knockout cell lysates for reproducible proteomic analysis

Abcam’s new engineered knockout cell lysates enable proteomic studies by providing researchers with “true negative” controls.

November 10, 2019
·
2 min read
Strong Quality of Life Data for Apogenix’ Asunercept Published in Journal of Neuro-Oncology

Asunercept Plus Radiotherapy Significantly Prolongs Time to Deterioration of Quality of Life Compared to Radiotherapy Alone in Patients with Recurrent Glioblastoma

November 10, 2019
·
4 min read
Business

SOTIO exercises second target option under existing collaboration with NBE-Therapeutics to develop next-generation antibody-drug conjugates

NBE-Therapeutics AG and SOTIO a.s. today announced that SOTIO has elected a second target for the development of a next generation antibody-drug conjugate under their existing license and collaboration agreement.

November 10, 2019
·
4 min read
Zelluna Immunotherapy presents data on its lead compound ZI-H04 at the Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Zelluna Immunotherapy, a biopharma company developing T-cell receptor guided adoptive cell therapy products for treatment of multiple solid cancers, announces it will present data on its lead TCR compound, ZI-H04 at a poster session.

November 10, 2019
·
1 min read
Lifebit Announces General Release of its Federated Genomics Cloud Operating System

Lifebit CloudOS operates as a managed informatics platform that removes the industry barrier of vast amounts of inaccessible distributed omics data, enables federated bioinformatics analysis and machine learning

November 10, 2019
·
3 min read
Policy

Reston Hospital Center Nationally Recognized With An ‘A’ Hospital Safety Grade by The Leapfrog Group

Reston Hospital Center was awarded an ‘A’ Leapfrog Hospital Safety Grade for fall 2019, a national distinction recognizing Reston’s achievements in protecting patients from harm and providing safer health care..

November 10, 2019
·
3 min read
Biotech Beach

New CRISPR-Cas9 design could improve therapies for HIV, sickle cell disease patients

This modified design for the CRISPR gene editing tool could eventually improve therapies for HIV and sickle cell disease

November 10, 2019
·
4 min read
Policy

China NMPA Approves Bio-Thera Solutions’ QLETLI® (格乐立®), A Biosimilar To Humira® (Adalimumab)

Bio-Thera Solutions, Ltd. announced that the China National Medical Products Administration has approved QLETLI® for all eligible indications of the reference product, Humira®, in China.

November 10, 2019
·
3 min read
UKI2S wins Best Sector Support Organisation at the OBN Awards

UK Innovation & Science Seed Fund is delighted to announce it is has been awarded ‘Best Sector Support Organisation’ at the 11th Annual OBN Awards celebration last night.

November 10, 2019
·
3 min read
Business

InflaRx Reports Third Quarter 2019 Financial & Operating Results

Recently announced results of open label extension part of SHINE Phase IIb study confirm potential of IFX-1 in Hidradenitis Suppurativa and warrant evaluation of future development

November 10, 2019
·
9 min read